# A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)

> **NCT07276724** · PHASE3 · RECRUITING · sponsor: **Generate Biomedicines** · enrollment: 786 (estimated)

## Conditions studied

- Severe Asthma

## Interventions

- **DRUG:** GB-0895
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07276724
- **Lead sponsor:** Generate Biomedicines
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-12-03
- **Primary completion:** 2028-12
- **Final completion:** 2028-12
- **Target enrollment:** 786 (ESTIMATED)
- **Last updated:** 2026-05-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07276724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07276724, "A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With Severe Uncontrolled Asthma (SOLAIRIA-1)". Retrieved via AI Analytics 2026-07-24 from https://api.ai-analytics.org/clinical/NCT07276724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*